A carregar...

Endothelin receptor antagonists in sickle cell disease: a promising new therapeutic approach

Sickle cell disease (SCD) is a genetic hematologic disorder that is characterized by a variety of potentially life threatening acute and chronic complications. Currently, hydroxyurea is the only clinically approved pharmacological therapy for the treatment of SCD, and the continued prevalence of sev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Life Sci
Main Authors: Fox, Brandon M., Kasztan, Malgorzata
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4992628/
https://ncbi.nlm.nih.gov/pubmed/27049871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2016.04.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!